Header Logo

Connection

ERIC STORCH to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications ERIC STORCH has written about Combined Modality Therapy.
ERIC STORCH
Connection Strength
2.857
Combined Modality Therapy
  1. Efficacy and acceptability of cognitive-behavioral therapy and serotonin reuptake inhibitors for pediatric obsessive-compulsive disorder: a network meta-analysis. J Child Psychol Psychiatry. 2024 05; 65(5):594-609.
    View in: PubMed
    Score: 0.172
  2. Efficacy of D-cycloserine augmented brief intensive cognitive-behavioural therapy for paediatric obsessive-compulsive disorder: A randomised clinical trial. Depress Anxiety. 2022 06; 39(6):461-473.
    View in: PubMed
    Score: 0.150
  3. Age moderated-anxiety mediation for multimodal treatment outcome among children with obsessive-compulsive disorder: An evaluation with correspondence analysis. J Affect Disord. 2021 03 01; 282:766-775.
    View in: PubMed
    Score: 0.139
  4. Improving long term patient outcomes from deep brain stimulation for treatment-refractory obsessive-compulsive disorder. Expert Rev Neurother. 2020 01; 20(1):95-107.
    View in: PubMed
    Score: 0.129
  5. Cost-Effectiveness of Treatment Alternatives for Treatment-Refractory Pediatric Obsessive-Compulsive Disorder. J Anxiety Disord. 2020 01; 69:102151.
    View in: PubMed
    Score: 0.129
  6. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis. J Anxiety Disord. 2019 12; 68:102149.
    View in: PubMed
    Score: 0.128
  7. Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders. J Child Psychol Psychiatry. 2020 04; 61(4):492-502.
    View in: PubMed
    Score: 0.127
  8. Sudden gains in cognitive behavioral therapy among children and adolescents with obsessive compulsive disorder. J Behav Ther Exp Psychiatry. 2019 09; 64:92-98.
    View in: PubMed
    Score: 0.123
  9. Fear extinction learning as a predictor of response to cognitive behavioral therapy for pediatric obsessive compulsive disorder. J Anxiety Disord. 2019 05; 64:1-8.
    View in: PubMed
    Score: 0.123
  10. Outpatient Treatment Patterns of Pediatric Obsessive-Compulsive Disorder. J Child Adolesc Psychopharmacol. 2017 Aug; 27(6):509-515.
    View in: PubMed
    Score: 0.108
  11. A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission. J Clin Psychiatry. 2017 02; 78(2):196-206.
    View in: PubMed
    Score: 0.106
  12. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2016 Aug 01; 73(8):779-88.
    View in: PubMed
    Score: 0.103
  13. A META-ANALYSIS OF COGNITIVE BEHAVIOR THERAPY AND MEDICATION FOR CHILD OBSESSIVE-COMPULSIVE DISORDER: MODERATORS OF TREATMENT EFFICACY, RESPONSE, AND REMISSION. Depress Anxiety. 2015 Aug; 32(8):580-93.
    View in: PubMed
    Score: 0.095
  14. Assessment and management of treatment-refractory obsessive-compulsive disorder in children. J Am Acad Child Adolesc Psychiatry. 2015 Apr; 54(4):251-62.
    View in: PubMed
    Score: 0.092
  15. Parental involvement in youth anxiety treatment: conceptual bases, controversies, and recommendations for intervention. J Anxiety Disord. 2015 Mar; 30:16-8.
    View in: PubMed
    Score: 0.092
  16. Cognitive behavior therapy for obsessive-compulsive and related disorders. Psychiatr Clin North Am. 2014 Sep; 37(3):415-45.
    View in: PubMed
    Score: 0.089
  17. Family-based exposure and response prevention therapy for preschool-aged children with obsessive-compulsive disorder: a pilot randomized controlled trial. Behav Res Ther. 2014 May; 56:30-8.
    View in: PubMed
    Score: 0.087
  18. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder. Behav Res Ther. 2013 Dec; 51(12):823-9.
    View in: PubMed
    Score: 0.084
  19. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy. Depress Anxiety. 2013 Aug; 30(8):723-31.
    View in: PubMed
    Score: 0.082
  20. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry. 2010 Dec 01; 68(11):1073-6.
    View in: PubMed
    Score: 0.069
  21. Defining treatment response and remission in obsessive-compulsive disorder: a signal detection analysis of the Children's Yale-Brown Obsessive Compulsive Scale. J Am Acad Child Adolesc Psychiatry. 2010 Jul; 49(7):708-17.
    View in: PubMed
    Score: 0.067
  22. Factors associated with poor response in cognitive-behavioral therapy for pediatric obsessive-compulsive disorder. Bull Menninger Clin. 2010; 74(2):167-85.
    View in: PubMed
    Score: 0.065
  23. Psychotherapy for obsessive-compulsive disorder. Curr Psychiatry Rep. 2009 Aug; 11(4):296-301.
    View in: PubMed
    Score: 0.063
  24. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder. Depress Anxiety. 2008; 25(2):172-4.
    View in: PubMed
    Score: 0.057
  25. Florida Obsessive-Compulsive Inventory: development, reliability, and validity. J Clin Psychol. 2007 Sep; 63(9):851-9.
    View in: PubMed
    Score: 0.055
  26. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol. 2007 Jul; 22(4):230-7.
    View in: PubMed
    Score: 0.055
  27. Sequential cognitive-behavioral therapy for children with obsessive-compulsive disorder with an inadequate medication response: a case series of five patients. Depress Anxiety. 2007; 24(6):375-81.
    View in: PubMed
    Score: 0.053
  28. D-Cycloserine augmentation of cognitive behavior therapy for pediatric OCD: Predictors and moderators of outcome. J Affect Disord. 2018 12 01; 241:454-460.
    View in: PubMed
    Score: 0.029
  29. Multimodal Residential Treatment for Adolescent Anxiety: Outcome and Associations with Pre-treatment Variables. Child Psychiatry Hum Dev. 2018 Jun; 49(3):434-442.
    View in: PubMed
    Score: 0.029
  30. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents. Brain Behav. 2018 06; 8(6):e00984.
    View in: PubMed
    Score: 0.029
  31. Family accommodation of anxiety symptoms in youth undergoing intensive multimodal treatment for anxiety disorders and obsessive-compulsive disorder: Nature, clinical correlates, and treatment response. Compr Psychiatry. 2018 01; 80:1-13.
    View in: PubMed
    Score: 0.028
  32. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry. 2017 05 01; 74(5):501-510.
    View in: PubMed
    Score: 0.027
  33. Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial. J Psychiatr Res. 2015 Dec; 71:140-7.
    View in: PubMed
    Score: 0.024
  34. Prospective relationship between obsessive-compulsive and depressive symptoms during multimodal treatment in pediatric obsessive-compulsive disorder. Child Psychiatry Hum Dev. 2014; 45(2):163-72.
    View in: PubMed
    Score: 0.021
  35. Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder. Depress Anxiety. 2009; 26(1):E23-5.
    View in: PubMed
    Score: 0.015
  36. Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol. 2006 Aug; 21(8):704-14.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.